Zum Hauptinhalt springen

Hepatitiden

08. April 2025 | Hepatitiden

Finding the Context of High-Risk Behavioral Factors and the Effectiveness of Addiction Treatment Centers in Preventing the Transmission of Hepatitis C Virus Among Injecting Drug Addicts: "Southeastern Iran".

Finding the Context of High-Risk Behavioral Factors and the Effectiveness of Addiction Treatment Centers in Preventing the Transmission of Hepatitis C Virus Among Injecting Drug Addicts: "Southeastern Iran". Asadi N, Pourkhajoei S. Hea…

08. April 2025 | Hepatitiden

Gender-based factors associated with hepatitis C testing in people who inject drugs: results from the French COSINUS cohort.

Gender-based factors associated with hepatitis C testing in people who inject drugs: results from the French COSINUS cohort. Anwar I, Faye A, Donadille C, Briand Madrid L, Lalanne L, Jauffret-Roustide M, Auriacombe M, Roux P; COSINUS Study Gr…

08. April 2025 | Hepatitiden

The association between drug injection duration and hepatitis C prevalence among people who inject drugs in Iran.

The association between drug injection duration and hepatitis C prevalence among people who inject drugs in Iran. Haji-Maghsoudi S, Tavakoli F, Mehmandoost S, Nasiri N, Haghdoost AA, Sharifi H. Sci Rep. 2025 Mar 25;15(1):10208. doi: 10…

08. April 2025 | Hepatitiden

Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of care.

Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of care. Klasa PE, Sandell M, Aleman S, Kåberg M. BMC Psychiatry. 2025 Mar 27;25(1):291. doi: 10.1186…

30. März 2025 | Hepatitiden

RKI. DRUCK-Surv - Surveillance von Drogen und chronischen Infektionskrankheiten

RKI. DRUCK-Surv - Surveillance von Drogen und chronischen Infektionskrankheiten Ziel Ziel von „DRUCK-Surv – Surveillance von Drogen und chronischen Infektionskrankheiten“ ist der Aufbau einer wiederkehrenden bundesweiten Datenerhebung zu Hepatitis…

11. März 2025 | Hepatitiden

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs).

A Comprehensive Review of Antiviral Therapy for Hepatitis C: The Long Journey from Interferon to Pan-Genotypic Direct-Acting Antivirals (DAAs). Di Marco L, Cannova S, Ferrigno E, Landro G, Nonni R, Mantia C, Cartabellotta F, Calvaruso V, Di M…

11. März 2025 | Hepatitiden

Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site.

Scaling up hepatitis C testing and linkage-to-care among people who use drugs: lessons learned from a pilot project implemented at a supervised consumption site. Hannigan A, Krishnan N, Singh K, Bytelaar S, Schmitz D, Bartlett S, Hall D, Barr…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten